Bionyx Biotech Private Limited

Wholesale retail of pharmaceutical products, incorporated in 2015, based in Uttar Pradesh.

2015 | Lucknow, Uttar Pradesh (India) | Active
Last Updated: January 03, 2025

Bionyx Biotech Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 9 Year, 3 Months
  • Last Filing with ROC 31 Mar 2024

About Bionyx Biotech

Bionyx Biotech Private Limited (BBPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 November 2015 (Nine years and three months 22 days old ). Its registered office is in Lucknow, Uttar Pradesh, India.

The Company is engaged in the Chemicals Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Rajneesh Srivastava and Shesh Chaudhary serve as directors at the Company.

Company Details

  • Location

    Lucknow, Uttar Pradesh, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U85191UP2015PTC074215

  • Company No.

    074215

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    02 Nov 2015

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Kanpur

Industry

Chemicals

Who are the key members and board of directors at Bionyx Biotech?

Board Members (2)

NameDesignationAppointment DateStatus
Rajneesh Srivastava Country flag representing In Director 02-Nov-2015Current
Shesh Chaudhary Country flag representing In Director 02-Nov-2015Current

Financial Performance of Bionyx Biotech.

Bionyx Biotech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Bionyx Biotech?

In 2017, Bionyx Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Bionyx Biotech?

Unlock and access historical data on people associated with Bionyx Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Bionyx Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bionyx Biotech's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Bionyx Biotech

Recent activity within the organization

  • Annual General Meeting

    Bionyx Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Bionyx Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.

    31 Mar 2024

  • Director Appointment

    Rajneesh Srivastava was appointed as a Director was appointed as a Director on 02 Nov 2015 & has been associated with this company since 9 years 3 months .

    02 Nov 2015

  • Director Appointment

    Shesh Ram Chaudhary was appointed as a Director was appointed as a Director on 02 Nov 2015 & has been associated with this company since 9 years 3 months .

    02 Nov 2015

  • Company Incorporation

    Bionyx Biotech Private Limited was registered on 02 Nov 2015 with Roc Kanpur & aged 9 years 3 months as per MCA records.

    02 Nov 2015

Frequently asked questions

  • Bionyx Biotech Private Limited was incorporated on 02 Nov 2015.

  • The authorized share capital of Bionyx Biotech Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Bionyx Biotech Private Limited.

    • Rajneesh Srivastava
    • Shesh Ram Chaudhary
  • As per Ministry of Corporate Affairs (Mca), the registered address of Bionyx Biotech Private Limited is G-1/69 Phase-Ii T.P. Nagar, India, Lucknow, Uttar Pradesh, 226002.

  • The corporate identification number (CIN) of Bionyx Biotech Private Limited is U85191UP2015PTC074215 and the company number is 074215 as per Ministry of Corporate Affairs (MCA).

  • The most recent Balance Sheet for Bionyx Biotech Private Limited was filed with the ROC on 31 Mar 2024.